International Stem Cell Corporation , a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business update and announced fourth quarter and year-end financial results for the year ended December 31, 2013.
http://ift.tt/1lLy9x5
http://ift.tt/1lLy9x5
No comments:
Post a Comment